Dan Carlson, Ph.D.
Chief Scientific Officer and SVP of Research & Development @ Recombinetics
4u8.fyuwzvv.kz.k@50zvj7jf50795.2v6
Sign up to see email
Known information
About Recombinetics
Recombinetics specializes in animal gene editing, focusing on biomedical research, regenerative medicine, and animal agriculture, with a significant role in xenotransplantation through its merger with Makana Therapeutics.